Medical Services Expenditures by Disease: Neoplasms Price Index, Blended Account Basis
NPSMSMPIBLEND • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
113.51
Year-over-Year Change
9.78%
Date Range
1/1/2000 - 1/1/2021
Summary
The Neoplasms Price Index, Blended Account Basis tracks medical expenditures related to the treatment of cancerous conditions in the U.S. This metric is a key indicator for healthcare economists and policymakers monitoring inflation in cancer-related medical services.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
This index measures the changes in prices paid for medical services and treatments specifically related to neoplasms, or cancerous growths. It provides a comprehensive view of price trends across different cancer care settings, including inpatient, outpatient, and prescription drug expenditures.
Methodology
The data is compiled by the U.S. Bureau of Economic Analysis using a variety of government and private sector sources.
Historical Context
This index helps policymakers and healthcare analysts understand cost pressures within the oncology segment of the medical services industry.
Key Facts
- The index has a base year of 2012.
- Cancer care represents over $200 billion in annual U.S. healthcare spending.
- Prices for cancer-related medical services have risen faster than overall healthcare inflation.
FAQs
Q: What does this economic trend measure?
A: This index measures changes in the prices paid for medical services and treatments related to the diagnosis and management of cancerous conditions in the United States.
Q: Why is this trend relevant for users or analysts?
A: This metric is important for healthcare economists and policymakers to monitor inflation in the oncology segment of the medical services industry.
Q: How is this data collected or calculated?
A: The data is compiled by the U.S. Bureau of Economic Analysis using a variety of government and private sector sources.
Q: How is this trend used in economic policy?
A: This index helps policymakers and healthcare analysts understand cost pressures within cancer care and inform decisions around healthcare spending and regulation.
Q: Are there update delays or limitations?
A: The index is updated quarterly, but there may be lags in the underlying data sources.
Related Trends
Medical Services Expenditures by Disease: Complications of Pregnancy; Childbirth; and the Puerperium Price Index, Blended Account Basis
COPRCHPIBLEND
Medical Services Expenditures by Disease: Diseases of the Digestive System Price Index, MEPS Account Basis
DIDISYPIMEPS
Medical Products, Appliances and Equipment Expenditures Price Index
MEAPEQPIHCSA
Medical Services Expenditures by Provider: Nursing Homes Price Index
NURHOMPIHCSA
Medical Services Expenditures by Provider: Dental Services Price Index
DENSERPIHCSA
Medical Services Expenditures by Provider: Nursing Homes: Proprietary and Government Nursing Homes Price Index
PRGONUPIHCSA
Citation
U.S. Federal Reserve, Medical Services Expenditures by Disease: Neoplasms Price Index, Blended Account Basis (NPSMSMPIBLEND), retrieved from FRED.